Clinical trial
A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
NCT01632423 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- November 30, 2010
- Enrollment
- 10,337 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.